Search Results - "Lambris, J.D."

Refine Results
  1. 1

    Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention by Mastellos, D.C., Ricklin, D., Hajishengallis, E., Hajishengallis, G., Lambris, J.D.

    Published in Molecular oral microbiology (01-02-2016)
    “…Summary There is increasing appreciation that complement dysregulation lies at the heart of numerous immune‐mediated and inflammatory disorders. Complement…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β by Ignatius, Anita, Schoengraf, Philipp, Kreja, Ludwika, Liedert, Astrid, Recknagel, Stefan, Kandert, Sebastian, Brenner, Rolf E., Schneider, Marion, Lambris, John D., Huber-Lang, Markus

    Published in Journal of cellular biochemistry (01-09-2011)
    “…There is a tight interaction of the bone and the immune system. However, little is known about the relevance of the complement system, an important part of…”
    Get full text
    Journal Article
  4. 4

    Differential capacity for complement receptor‐mediated immune evasion by Porphyromonas gingivalis depending on the type of innate leukocyte by Hajishengallis, G., Krauss, J.L., Jotwani, R., Lambris, J.D.

    Published in Molecular oral microbiology (01-04-2017)
    “…Summary The complement system plays a central role in immunity and inflammation, although certain pathogens can exploit complement to undermine protective…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood by Danielsson, A, Elgue, G, Nilsson, B M, Nilsson, B, Lambris, J D, Tötterman, T H, Kochanek, S, Kreppel, F, Essand, M

    Published in Gene therapy (01-06-2010)
    “…Polyethylene glycol coating (PEGylation) of adenovirus serotype 5 (Ad5) has been shown to effectively reduce immunogenicity and increase circulation time of…”
    Get full text
    Journal Article
  11. 11

    Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb‐C and its complement target C3d by Haspel, Nurit, Ricklin, Daniel, Geisbrecht, Brian V., Kavraki, Lydia E., Lambris, John D.

    Published in Protein science (01-11-2008)
    “…The C3–inhibitory domain of Staphylococcus aureus extracellular fibrinogen‐binding protein (Efb‐C) defines a novel three‐helix bundle motif that regulates…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    CD59 Efficiently Protects Human NT2-N Neurons Against Complement-mediated Damage by Pedersen, E.D, Aass, H.C.D, Rootwelt, T, Fung, M, Lambris, J.D, Mollnes, T.E

    Published in Scandinavian journal of immunology (01-08-2007)
    “…The complement regulatory protein CD59 controls cell survival by the inhibition of C5b-9 formation on the cell membrane. Loss of CD59 increases the…”
    Get full text
    Journal Article
  17. 17

    Improvement of the anti-C3 activity of compstatin using rational and combinatorial approaches by Morikis, D, Soulika, A M, Mallik, B, Klepeis, J L, Floudas, C A, Lambris, J D

    Published in Biochemical Society transactions (01-02-2004)
    “…Compstatin is a 13-residue cyclic peptide that has the ability to inhibit the cleavage of C3 to C3a and C3b. The effects of targeting C3 cleavage are…”
    Get more information
    Journal Article
  18. 18
  19. 19

    From atoms to systems: a cross-disciplinary approach to complement-mediated functions by Mastellos, D, Morikis, D, Strey, C, Holland, M.C, Lambris, J.D

    Published in Molecular Immunology (01-06-2004)
    “…With an ever-increasing wealth of information made available to researchers from expanding genomic sequence and protein structure databases, traditional…”
    Get full text
    Book Review Journal Article
  20. 20

    Drusen complement components C3a and C5a promote choroidal neovascularization by Nozaki, M., Raisler, B.J., Sakurai, E., Sarma, J.V., Barnum, S.R., Lambris, J.D., Chen, Y., Zhang, K., Ambati, B.K., Baffi, J.Z., Ambati, J.

    Published in American journal of ophthalmology (01-07-2006)
    “…The earliest clinical hallmark of age-related macular degeneration (AMD) is the presence of drusen, extracellular deposits that accumulate beneath the retinal…”
    Get full text
    Journal Article